Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · IEX Real-Time Price · USD
8.49
-0.43 (-4.77%)
Jan 27, 2022 3:38 PM EST - Market open

Balance Sheet (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20202019
Cash & Equivalents
39.0516.84
Cash & Cash Equivalents
39.0516.84
Cash Growth
131.80%-
Other Current Assets
0.90.59
Total Current Assets
39.9517.44
Property, Plant & Equipment
3.040.8
Other Long-Term Assets
0.540
Total Long-Term Assets
3.580.8
Total Assets
43.5318.24
Accounts Payable
1.60.71
Other Current Liabilities
1.761.21
Total Current Liabilities
3.361.92
Other Long-Term Liabilities
-0.02
Total Long-Term Liabilities
00.02
Total Liabilities
3.361.94
Common Stock
1.020.47
Retained Earnings
-42.51-15.99
Shareholders' Equity
-41.49-15.52
Total Liabilities and Equity
-38.13-13.58
Net Cash / Debt
39.0516.84
Net Cash / Debt Growth
131.80%-
Net Cash Per Share
4.882.49
Working Capital
36.5915.52
Book Value Per Share
-5.19-2.30
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).